Sean Stewart, a former executive with JP Morgan and Perella Weinberg Partners who is accused of insider trading based on his work on several medical device transactions, lost his bid to have criminal charges dismissed from a federal court in New York. Federal prosecutors in May 2015 charged Stewart, his father Robert Stewart and a 3rd […]
DiagnoCure said last week it sold its PCA3 prostate cancer biomarker assets to Hologic‘s (NSDQ:HOLX) subsidiary Gen-Probe for $4.7 million (C$6.5 million). The purchase is slated to include $4 million (C$5.5 million) in cash and the repurchase of 4.9 million series A convertible preferred shares of DiagnoCure held by Gen-Probe, valued at $744,229 (C$1 million). “The […]
Analyst: ConMed ripe for M&A spree May 19, 2015 by Fink Densford ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter. Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in […]
Hull manned the corner office at Gen-Probe up until Hologic acquired the company in a deal worth almost $4 billion, after which he took on a role as the senior vice president and general manager of diagnostics.
Massachusetts-based women’s health devices maker Hologic (NSDQ:HOLX) may shutter a Madison, Wisc. manufacturing facility, according to an internal memo obtained by the Milwaukee-Wisconsin Journal Sentinel.
The closure will "likely" take place within 18 months of closure of Hologic’s $3.7 billion Gen-Probe acquisition, according to a memo dated June 13.